Amylyx Pharmaceuticals Q4 2025 Earnings Preview
Source: SeekingAlpha
2026-03-02 17:35:38 ET
More on Amylyx Pharmaceuticals
- Amylyx Pharmaceuticals: Back From The Dead
- Amylyx Pharmaceuticals, Inc. (AMLX) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
- Seeking Alpha’s Quant Rating on Amylyx Pharmaceuticals
- Historical earnings data for Amylyx Pharmaceuticals
- Financial information for Amylyx Pharmaceuticals
Read the full article on Seeking Alpha
For further details see:
Amylyx Pharmaceuticals Q4 2025 Earnings Preview
Amylyx Pharmaceuticals Inc.
NASDAQ: AMLX
AMLX Trading
8.94% G/L:
$14.925 Last:
234,342 Volume:
$14.31 Open:
AMLX Latest News
March 03, 2026 07:00:00 am
Amylyx Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results
February 24, 2026 09:00:00 am
Amylyx Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results on March 3, 2026
AMLX Stock Data
$1,635,213,382
76,324,600
0.74%
41
N/A
Biotechnology & Life Sciences
Healthcare
US
Cambridge
